Gareth Pryce

8.6k total citations
104 papers, 6.5k citations indexed

About

Gareth Pryce is a scholar working on Immunology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Gareth Pryce has authored 104 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Immunology, 35 papers in Pharmacology and 31 papers in Pathology and Forensic Medicine. Recurrent topics in Gareth Pryce's work include Cannabis and Cannabinoid Research (35 papers), Multiple Sclerosis Research Studies (31 papers) and Neuroinflammation and Neurodegeneration Mechanisms (17 papers). Gareth Pryce is often cited by papers focused on Cannabis and Cannabinoid Research (35 papers), Multiple Sclerosis Research Studies (31 papers) and Neuroinflammation and Neurodegeneration Mechanisms (17 papers). Gareth Pryce collaborates with scholars based in United Kingdom, United States and Netherlands. Gareth Pryce's co-authors include David Baker, Gavin Giovannoni, David Male, J. Ludovic Croxford, Vincenzo Di Marzo, Roger G. Pertwee, Klaus Schmierer, Peter Brown, Samuel J. Jackson and Alan J. Thompson and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Gareth Pryce

103 papers receiving 6.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gareth Pryce United Kingdom	43	2.9k	1.8k	1.4k	1.4k	1.2k	104	6.5k
Fabián Docagne France	41	1.2k 0.4×	1.2k 0.7×	369 0.3×	540 0.4×	1.4k 1.2×	74	4.7k
J. Ludovic Croxford United States	22	1.8k 0.6×	935 0.5×	578 0.4×	840 0.6×	534 0.4×	27	3.1k
Eugene D. Ponomarev Hong Kong	31	686 0.2×	636 0.4×	433 0.3×	1.6k 1.2×	1.6k 1.3×	53	4.8k
Haim Ovadia Israel	38	449 0.2×	697 0.4×	492 0.3×	675 0.5×	1.2k 1.0×	145	4.4k
Gila Moalem‐Taylor Australia	37	435 0.1×	1.7k 1.0×	869 0.6×	867 0.6×	1.1k 0.9×	67	5.6k
Carmela R. Abraham United States	48	709 0.2×	1.4k 0.8×	379 0.3×	614 0.4×	3.7k 3.1×	126	9.1k
M. L. Cuzner United Kingdom	52	422 0.1×	1.5k 0.9×	2.4k 1.7×	2.7k 2.0×	2.7k 2.2×	133	9.2k
Kazuhito Tsuboi Japan	39	3.5k 1.2×	847 0.5×	551 0.4×	644 0.5×	1.5k 1.2×	92	5.8k
A. Léon Italy	35	1.0k 0.4×	2.3k 1.3×	273 0.2×	411 0.3×	1.6k 1.3×	94	4.6k
Klaus Fink Germany	39	364 0.1×	2.8k 1.6×	339 0.2×	1.1k 0.8×	4.0k 3.3×	82	7.4k

Countries citing papers authored by Gareth Pryce

Since Specialization

Citations

This map shows the geographic impact of Gareth Pryce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gareth Pryce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gareth Pryce more than expected).

Fields of papers citing papers by Gareth Pryce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gareth Pryce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gareth Pryce. The network helps show where Gareth Pryce may publish in the future.

Co-authorship network of co-authors of Gareth Pryce

This figure shows the co-authorship network connecting the top 25 collaborators of Gareth Pryce. A scholar is included among the top collaborators of Gareth Pryce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gareth Pryce. Gareth Pryce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pancholi, Jessica, Gareth Pryce, Laura J. McCormick, et al.. (2024). Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration. Science Advances. 10(28). eado3501–eado3501. 3 indexed citations

Baker, David, Gareth Pryce, Louisa K. James, Mónica Marta, & Klaus Schmierer. (2020). The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis.. Multiple Sclerosis and Related Disorders. 44. 102279–102279. 91 indexed citations

Baker, David, et al.. (2019). Potential mechanisms of action related to the efficacy and safety of cladribine. Multiple Sclerosis and Related Disorders. 30. 176–186. 54 indexed citations

Pryce, Gareth & David Baker. (2018). Oligoclonal bands in multiple sclerosis; Functional significance and therapeutic implications. Does the specificity matter?. Multiple Sclerosis and Related Disorders. 25. 131–137. 37 indexed citations

Peferoen, Laura A. N., Annamaria Finardi, David Baker, et al.. (2015). Pentraxin‐3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. European Journal of Immunology. 46(3). 701–711. 25 indexed citations

Hampton, David W., Andrea Serio, Gareth Pryce, et al.. (2013). Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis. Acta Neuropathologica Communications. 1(1). 84–84. 25 indexed citations

Puentes, Fabìola, Markus Kipp, Cordian Beyer, et al.. (2013). Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 10(1). 118–118. 9 indexed citations

Pryce, Gareth, Cristina Visintin, Sreeram V Ramagopalan, et al.. (2013). Control of spasticity in a multiple sclerosis model using central nervous system‐excluded CB ₁ cannabinoid receptor agonists. The FASEB Journal. 28(1). 117–130. 23 indexed citations

Pryce, Gareth, Sandra Amor, Wouter H. Gerritsen, et al.. (2011). Selective targeting of neuroprotection to MS lesions: sodium channel blockers in experimental autoimmune encephalomyelitis. UCL Discovery (University College London). 1 indexed citations

10.

Ayoub, Samir S., Gareth Pryce, Michael Seed, et al.. (2011). Paracetamol-Induced Hypothermia Is Independent of Cannabinoids and Transient Receptor Potential Vanilloid-1 and Is Not Mediated by AM404. Drug Metabolism and Disposition. 39(9). 1689–1695. 18 indexed citations

11.

East, Emma, Djordje Gverić, David Baker, et al.. (2007). Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor‐1 knockout mice: the effect of fibrinolysis during neuroinflammation. Neuropathology and Applied Neurobiology. 34(2). 216–230. 20 indexed citations

12.

Baker, David, Samuel J. Jackson, & Gareth Pryce. (2007). Cannabinoid control of neuroinflammation related to multiple sclerosis. British Journal of Pharmacology. 152(5). 649–654. 55 indexed citations

13.

Gegg, Matthew E., Rachel A. Harry, Deborah J.R. Hankey, et al.. (2005). Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction. The Journal of Immunology. 174(4). 2327–2335. 59 indexed citations

14.

Smith, Paul A., M. Morris-Downes, Nicole Heijmans, et al.. (2005). Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice. Journal of Neuroimmunology. 164(1-2). 76–84. 24 indexed citations

15.

Ligresti, Alessia, Maria Grazia Cascio, Gareth Pryce, et al.. (2005). New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. British Journal of Pharmacology. 147(1). 83–91. 53 indexed citations

16.

Pryce, Gareth, Gavin Giovannoni, & David Baker. (2003). Mifepristone or inhibition of 11β-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Δ(9)-tetrahydrocannabinol in mice. Neuroscience Letters. 341(2). 164–166. 21 indexed citations

17.

Walters, Claire E., Gareth Pryce, Deborah J.R. Hankey, et al.. (2002). Inhibition of Rho GTPases with Protein Prenyltransferase Inhibitors Prevents Leukocyte Recruitment to the Central Nervous System and Attenuates Clinical Signs of Disease in an Animal Model of Multiple Sclerosis. The Journal of Immunology. 168(8). 4087–4094. 96 indexed citations

18.

Ahmed, Zubair, Gareth Pryce, Deanna L. Taylor, et al.. (2002). A Role for Caspase-1 and -3 in the Pathology of Experimental Allergic Encephalomyelitis. American Journal Of Pathology. 161(5). 1577–1586. 44 indexed citations

19.

Male, David & Gareth Pryce. (1989). Induction of Ia molecules on brain endothelium is related to susceptibility to experimental allergic encephalomyelitis. Journal of Neuroimmunology. 21(1). 87–90. 42 indexed citations

20.

Banga, J. Paul, Gareth Pryce, L Hammond, & Ivan M. Roitt. (1984). Characterization of the human thyroid microsomal antigen involved in thyroid autoimmunity. Biochemical Society Transactions. 12(6). 1118–1119. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact